MGD 4.1 Chromosomal abnormalities

Chromosomes: structure and basic concepts

  • A chromosome consists of proteins and one long molecule of DNA.

  • Each chromosome has a short arm (p) and a long arm (q) connected by a centromere.

  • A chromatid is one of two identical halves of a replicated chromosome.

  • Before cell division (M phase), chromosomes replicate (S phase) so that each daughter cell receives a complete set of chromosomes.

  • In humans, a diploid cell has 46 chromosomes: 2222 pairs of autosomes and 11 pair of sex chromosomes (total 4646).

Karyotype, karyogram, and ideogram

  • A karyotype is the actual picture of an individual’s collection of chromosomes.
  • A karyotype is a preparation of the complete set of metaphase chromosomes in cells, sorted by length, centromere location, and other features.
  • A karyogram is the arrangement of the whole set of chromosomes in pairs by size and centromere position.
  • Distinction:
    • Karyotype describes chromosome number and their appearance.
    • Karyogram is the visual arrangement of the chromosomes in pairs by size and centromere position.
  • Reference formats: the standard reporting uses the diploid number and sex chromosomes, e.g. 46,XX46,\,XX (normal female) or 46,XY46,\,XY (normal male).

Chromosome ideogram and banding

  • A chromosome ideogram is a graphical representation of chromosomes.
  • GTG/G-banding (Giemsa staining) produces visible karyotypes by staining condensed chromosomes.
  • Dark and light bands are numbered according to international convention: ISCN 2013.
  • Giemsa (G-banding) is a nucleic acid stain used in cytogenetics.

Karyotyping: process and sources

  • Karyotyping is the process of pairing and ordering all the chromosomes of an individual.
  • It detects changes in chromosome number and structural changes (deletions, duplications, translocations, inversions).
  • Karyotypes are prepared from mitotic cells arrested in metaphase or prometaphase when chromosomes are most condensed.
  • Possible tissue sources: peripheral blood, skin biopsy, tumour biopsies, or bone marrow (cancer).
  • For prenatal diagnosis, sources include amniotic fluid or chorionic villus samples.

Indications for karyotyping

1) Prenatal screening:

  • Down syndrome, especially with maternal age > 3535 years.
  • Family history of chromosomal abnormalities.
  • Abnormal ultrasound scan of the fetus.

2) Birth defects:

  • Malformations.
  • Mental or developmental impairment.

3) Abnormal sexual development:

  • Klinefelter syndrome (47,XXY), Turner syndrome (45,X).

4) Infertility; recurrent fetal loss.

5) Leukemia and other cancers.

Chromosomal abnormalities: overview

  • Polyploidy: possession of more than two complete sets of chromosomes.
  • Aneuploidy: abnormal number of chromosomes for autosomes or sex chromosomes.
  • Chromosomal mutations (structural):
    • Deletion
    • Duplication
    • Inversion
    • Insertion
    • Translocation

Polyploidy

  • Definition: polyploidy is the heritable condition of possessing more than two complete sets of chromosomes.

  • Most polyploids have an even number of chromosome sets; the most common in plants is tetraploidy (4n).

  • Polyploids are common in plants, some fish, and amphibians; often fit and well adapted.

  • In some animal tissues, polyploidy can occur in otherwise diploid organisms (endopolyploidy, e.g., human muscle tissues).

  • Example: many strawberry species and hybrids can be diploid (2n), tetraploid (4n), pentaploid (5n), hexaploid (6n), etc.

  • In humans, true polyploidy is lethal or extremely rare; triploidy (6969 chromosomes) and tetraploidy (9292 chromosomes) occur in pregnancies and miscarriages.

  • Triploidy is usually due to polyspermy (one egg fertilised by more than one sperm) and occurs in about 2ext3%2 ext{-}3\% of all pregnancies and ~15%15\% of miscarriages.

  • Complete tetraploidy is rarer but observed in about 1ext2%1 ext{-}2\% of early miscarriages.

  • Why polyploidy can be lethal: abnormal chromosome sets disrupt normal cell function.

  • Examples (species): strawberries can be ddifferent ploidies; in humans, polyploidy is generally not compatible with life.

Aneuploidy

  • Definition: presence of an abnormal number of chromosomes in a cell (usually one more or one less).

  • It is the most common and clinically significant human chromosome abnormality, occurring in at least 3ext4%3 ext{-}4\% of all clinically recognised pregnancies.

  • In humans, the most common aneuploidies are trisomies (three copies of a chromosome), representing about 0.3%0.3\% of all live births.

  • With few exceptions, trisomies are not compatible with life; trisomies account for about 35%35\% of spontaneous abortions.

  • Most common mechanism: nondisjunction during meiosis (failure of homologous chromosomes or sister chromatids to separate properly).

  • Maternal meiosis I is the most likely stage because oocytes can be arrested in prophase I for decades.

  • The risk of trisomy increases with maternal age; women > 3535 are routinely offered testing for fetal chromosome abnormalities.

Autosomal trisomies: viable examples

  • Viable autosomal trisomies are limited to a few chromosomes:
    • Trisomy 2121: Down syndrome (viable)
    • Trisomy 1818: Edwards syndrome (viable, but severe)
    • Trisomy 1313: Patau syndrome (viable to a limited extent)
  • Trisomy 2121 is the only viable autosomal trisomy with the smallest predicted protein-coding content on chromosome 2121 (except the Y chromosome), making the perturbation less severe.
  • Trisomy 21 is most commonly caused by full trisomy; mosaic and translocation variants exist.
  • Down syndrome karyotype: 47,XX,+2147,\,XX,+21 or 47,XY,+2147,\,XY,+21.
  • Trisomy 21 affected individuals have characteristic facial features and increased risk of certain health issues.

Down syndrome: clinical features and epidemiology

  • Karyotype: 47,XX,+2147,\,XX,+21 or 47,XY,+2147,\,XY,+21 (and mosaic/translocation variants exist).
  • Incidence: about 1/800 to 1/10001/800\text{ to }1/1000 live births (more common in males: approximately 1.15:1).
  • Distinct facial features: flattened face, small head, short neck, protruding tongue, upward slanting palpebral fissures, small ears, poor muscle tone.
  • Hands/feet: broad, short hands with a single palmar crease; short fingers; small hands/feet; excess flexibility.
  • Iris: Brushfield spots (tiny white spots).
  • Growth and development: intellectual disability (IQ ~3535{-}70).
  • Health associations: congenital heart disease, higher risk of haematological malignancies (ALL risk ~10x higher), hypothyroidism, GI issues (e.g., constipation due to lack of nerves in colon), infertility (males infertile, females reduced fertility), eye and hearing disorders.

Edwards syndrome: clinical and epidemiology

  • Karyotype: 47,XX,+1847,\,XX,+18 (or 47,XY,+1847,\,XY,+18).
  • Incidence: around 1/60001/6000 live births; ~80% of affected individuals are female.
  • Typical lifespan: 5ext155 ext{-}15 days, with 5ext10%5 ext{-}10\% surviving beyond 1 year.
  • Population data (2019, England and Wales): 95 live births with Edwards’ syndrome; mortality rate ~98.1%98.1\% in the same year.
  • Features: intrauterine growth retardation; low birth weight; potential heart defects and other organ abnormalities; severe intellectual disability; weak cry and limited response to sound.

Patau syndrome: clinical features and epidemiology

  • Karyotype: 47,XY,+1347,\,XY,+13 (or 47,XX,+1347,\,XX,+13).
  • Incidence: about 1/10,000extto1/21,7001/10{,}000 ext{ to }1/21{,}700 live births.
  • Survival: 5ext10%5 ext{-}10\% live past the first year; a small percentage reach early adulthood.
  • Features: multiple congenital abnormalities including severe intellectual disability, congenital heart defects, brain or spinal cord abnormalities, microphthalmia (very small eyes), low-set ears, polydactyly (extra fingers/toes), cleft lip/palate, hypotonia.

Sex chromosome aneuploidies and X inactivation

  • Humans tolerate extra sex chromosomes better than extra autosomes due to X inactivation and the small gene content on the Y chromosome.
  • Affected individuals typically show reduced sexual development and fertility, but may have normal life spans and responsive symptoms to hormone therapies.
  • Common conditions:
    • Turner syndrome: 45,X45,X
    • Triple X syndrome: 47,XXX47,XXX
    • Klinefelter syndrome: 47,XXY47,XXY
    • XYY syndrome: 47,XYY47,XYY

X chromosome inactivation (Lyonization)

  • X inactivation is a random transcriptional silencing of one of the two X chromosomes in female cells during development.
  • Inactivation is stable; the same X chromosome remains inactive in all progeny cells.
  • Result: females are a mosaic of cells with either the maternally inherited or paternally inherited X silenced.
  • Barr body: an inactive X chromosome visible as a dense chromatin body in the nucleus.

Turner syndrome: 45,X

  • Epidemiology: the most common sex chromosome abnormality in females; occurs in 1/20001/2000 to 1/25001/2500 live female births (roughly 10% of miscarriages are 45,X).
  • Proportion with lifespan extending beyond infancy is low; some may reach early adulthood.
  • Common congenital features: multiple anatomical abnormalities; high risk for cardiovascular and kidney issues; short stature; incomplete pubertal development without hormone therapy.
  • Symptoms:
    • Short stature
    • Delayed or absent sexual development (no breast development; absent or irregular menses; small ovaries; potential need for hormone therapy)
    • Cardiovascular problems (bicuspid aortic valve, coarctation of the aorta, aortic arch elongation, hypertension)
    • Kidney defects in about 30%30\% to 40%40\% of individuals
    • Hearing problems (hearing loss in >50%50\% in adulthood)
    • No mental retardation typically

Triple X syndrome: 47,XXX

  • Incidence: about 1/10001/1000 live births; most are undiagnosed.
  • X inactivation: two of the three X chromosomes are inactivated, leaving one active.
  • Phenotype: highly variable; many have no noticeable effects or only mild symptoms.
  • Common feature: taller than average height.
  • Sometimes more significant symptoms occur, varying among individuals.

Klinefelter syndrome: 47,XXY

  • Incidence: about 1/500 to 1/10001/500\text{ to }1/1000 live male births.
  • Onset: symptoms typically appear after puberty.
  • Common physical features: taller, less muscular body; gynecomastia (breast tissue development).
  • Management: sex hormone therapy and surgical options as needed.

XYY syndrome: 47,XYY

  • Incidence: about 1/10001/1000 live male births.
  • Phenotype: not really a syndrome; often near-normal phenotype.
  • Characteristics: increased growth rate in early childhood (about +7 cm taller than average) and normal testosterone levels and fertility.
  • IQ: typically within normal range but on average ~10 to 15 points lower than siblings.
  • Noted in popular media but lacks convincing evidence of a higher rate of criminal behavior.

Chromosomal translocations and related concepts

  • Chromosomes can break and reattach to other chromosomes; breakpoints often lie between genes, so a balanced translocation carrier typically has a full gene complement and no phenotype.
  • However, there is a risk of passing on derivative chromosomes to offspring, which can result in unbalanced offspring with phenotypic abnormalities.

Robertsonian translocation

  • Formed by breakage of two acrocentric chromosomes (nos. 13, 14, 15, 21, 22) near their centromeres, with fusion of their long arms.
  • Resulting total chromosome number is reduced to 4545.
  • Carriers are usually phenotypically normal since there is no net loss of essential genetic material.
  • Incidence in the population is about 1/10001/1000, with the most common fusion being between chromosomes 1313 and 1414.

Philadelphia chromosome and therapy implications

  • Philadelphia chromosome results from a reciprocal translocation between chromosomes 99 and 2222: t(9;22)(q34;q11)t(9;22)(q34;q11).
  • This translocation creates the BCR-ABL fusion gene, encoding an oncogenic protein.
  • Therapy: BCR-ABL tyrosine-kinase inhibitors (TKIs) are first-line therapy for most patients with chronic myeloid leukemia (CML).

Deletions and other mutations

  • Deletion example: deletion of the short arm of chromosome 17p17p (17p) is found in 5ext8%5 ext{-}8\% of chronic lymphocytic leukemia (CLL) patients and is associated with rapid disease progression and poor response to treatment.

Visualising chromosomes: FISH and beyond

  • Fluorescence in situ hybridization (FISH) uses fluorescent probes to detect specific DNA sequences on chromosomes.

  • Example: a fluorescent signal marks a specific locus; multiple probes can be used simultaneously to order segments relative to one another.

  • Interphase FISH can detect chromosomal abnormalities in non-dividing cells.

  • Applications: Charcot–Marie–Tooth syndrome duplication (evident as three signals for a locus), Philadelphia chromosome (green and red signals).

  • Spectral karyotyping (SKY) and multicolor-FISH (M-FISH):

    • Paint each human chromosome in one of 24 colors.
    • Probe mixtures are hybridized and detected using multiple fluorescence filters.
    • M-FISH is a 24-color karyotyping technique and the method of choice for studying complex interchromosomal rearrangements.
    • Process involves metaphase chromosome preparations and labeling of chromosome-painting probes.
    • 24 chromosome painting probes plus Cot-1 DNA are used.
    • There is a 24-color scheme to distinguish all chromosomes.

Aneuploidy visual summaries

  • Common examples shown: Down Syndrome, Klinefelter Syndrome, Turner Syndrome.

Summary (key takeaways)

  • Chromosomes vary in shape and size; they come in pairs with characteristic banding patterns and identifiable features.
  • Karyotyping can identify chromosomal abnormalities from a small cell sample.
  • Large-scale chromosomal abnormalities are usually lethal; smaller-scale abnormalities can be viable but cause varying phenotypes.
  • Automated visualization techniques (FISH, SKY, M-FISH) enable efficient screening and complex rearrangement analysis.

Notation quick reference

  • Normal human karyotype formats: 46,XX46,\,XX or 46,XY46,\,XY.
  • Autosomal trisomies can be denoted as 46,XX,+2146,\,XX,+21, 46,XY,+2146,\,XY,+21, etc.
  • Monosomy: e.g., Turner syndrome 45,X45,X.
  • Translocations: t(9;22)(q34;q11)t(9;22)(q34;q11) (Philadelphia chromosome).
  • Deletions: 17p17p deletion.
  • Polyploidy: 3n,4n3n, 4n (triploidy, tetraploidy) corresponding to 6969 or 9292 chromosomes respectively.